Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Zalcberg

Showing results (21-30 of 150) with videos related to

Pageof 15
Sort By:
Cancer Biology & Therapy|August 6, 2005
Signal therapy of breast cancers by the HDAC inhibitor FK228 that blocks the activation of PAK1 and abrogates the tamoxifen-resistanceYumiko Hirokawa, Melissa Arnold, Hidenori Nakajima, et al.
ANZ Journal of Surgery|July 31, 2003
Is improving local control sufficient indication for radiotherapy in the management of rectal cancer? A responseSamuel Y K Ngan, David Goldstein, Michael Solomon, et al.
ANZ Journal of Surgery|October 22, 2021
A comparison of outcomes and survival between Victoria and Denmark in lung cancer surgery: opportunities for international benchmarkingMichael Stenger, Erik Jakobsen, Gavin Wright, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 23, 2024
A cost comparison of pembrolizumab: Fixed and weight-based dosingAnn-Louise Slee, John Coutsouvelis, Bianca Tong, et al.
Asia-Pacific Journal of Clinical Oncology|July 22, 2021
Improving regional access: Phase 1 teletrials in the era of COVID-19Gregory Gaughran, John Zalcberg, Cheryl-Ann Hawkins, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 15, 2021
Effect of Follow-Up Surveillance After Curative-Intent Treatment of NSCLC on Detection of New and Recurrent Disease, Retreatment, and Survival: A Systematic Review and Meta-AnalysisRob G Stirling, Cerys Chau, Ali Shareh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2008
Discussing expensive anticancer drugsMichael Jefford, Linda Mileshkin, Penelope Schofield, et al.
Journal of Telemedicine and Telecare|July 8, 2021
Implementation of the Australasian Teletrial Model: Translating ideas into action using implementation science frameworksSabe Sabesan, Marie Malica, Chantal Gebbie, et al.
The Lancet. Oncology|March 3, 2007
Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysisVal Gebski, Bryan Burmeister, B Mark Smithers, et al.
Cancer Medicine|May 20, 2026
Paediatric and Adult Solid Tumours Exhibiting NTRK Gene Fusions in Australia, 2020-2044: A Population-Based Statistical Modelling StudyQingwei Luo, Yoon-Jung Kang, Jeff Cuff, et al.
Pageof 15

Showing results (21-30 of 150) with videos related to

Sort By:
Pageof 15
Cancer Biology & Therapy|August 6, 2005
Signal therapy of breast cancers by the HDAC inhibitor FK228 that blocks the activation of PAK1 and abrogates the tamoxifen-resistanceYumiko Hirokawa, Melissa Arnold, Hidenori Nakajima, et al.
ANZ Journal of Surgery|July 31, 2003
Is improving local control sufficient indication for radiotherapy in the management of rectal cancer? A responseSamuel Y K Ngan, David Goldstein, Michael Solomon, et al.
ANZ Journal of Surgery|October 22, 2021
A comparison of outcomes and survival between Victoria and Denmark in lung cancer surgery: opportunities for international benchmarkingMichael Stenger, Erik Jakobsen, Gavin Wright, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 23, 2024
A cost comparison of pembrolizumab: Fixed and weight-based dosingAnn-Louise Slee, John Coutsouvelis, Bianca Tong, et al.
Asia-Pacific Journal of Clinical Oncology|July 22, 2021
Improving regional access: Phase 1 teletrials in the era of COVID-19Gregory Gaughran, John Zalcberg, Cheryl-Ann Hawkins, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 15, 2021
Effect of Follow-Up Surveillance After Curative-Intent Treatment of NSCLC on Detection of New and Recurrent Disease, Retreatment, and Survival: A Systematic Review and Meta-AnalysisRob G Stirling, Cerys Chau, Ali Shareh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2008
Discussing expensive anticancer drugsMichael Jefford, Linda Mileshkin, Penelope Schofield, et al.
Journal of Telemedicine and Telecare|July 8, 2021
Implementation of the Australasian Teletrial Model: Translating ideas into action using implementation science frameworksSabe Sabesan, Marie Malica, Chantal Gebbie, et al.
The Lancet. Oncology|March 3, 2007
Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysisVal Gebski, Bryan Burmeister, B Mark Smithers, et al.
Cancer Medicine|May 20, 2026
Paediatric and Adult Solid Tumours Exhibiting NTRK Gene Fusions in Australia, 2020-2044: A Population-Based Statistical Modelling StudyQingwei Luo, Yoon-Jung Kang, Jeff Cuff, et al.
Pageof 15